Menu Menu

CALT    Calliditas Therapeutics Ab    1795579    
Income Statement
Net Income -47,478,000

Balance Sheet
Current Assets 1,154,464,000
Assets 1,747,205,000
Current Liabilities 429,778,000
Liabilities 1,640,416,000
Equity 106,789,000
Shares Out 59,580,000

Cash Flow Statement
Operating Cash Flow -7,043,000
Investing Cash Flow -102,000

Market Analysis
Market Cap 1,212,299,701
Price 6.70
BVPS 1.79
PB 3.74
EPS -1.92
PS 1.70
FCF -7,145,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/21
Apr May Jun
5/23
Jul Aug Sep
8/13
Oct Nov Dec
11/11

Find a discrepancy? The most accurate way to find company fundamental data is to view CALT documents filed with the SEC.


CALT Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: